NSCLC lift for Boehringer
June 4, 2013Research and Development, Sales and Marketing Boehringer, NSCLC
Boehringer’s pipeline has been boosted with the news that its investigational oral triple angiokinase inhibitor nintedanib plus chemotherapy, extends the …
Boehringer and Lilly launch diabetes game
June 4, 2013Medical Communications Boehringer Ingelheim, combat, lilly
Boehringer Ingelheim and Eli Lilly have launched an educational digital game for type 2 diabetes called Complications Combat. The game …
Vocera appoints president and chief executive
June 4, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brent Lang, Vocera
Healthcare comms firm Vocera Communications has announced Brent Lang’s appointment as president and chief executive officer to the firm and …
UK government cautious on trial transparency
June 4, 2013Research and Development, Sales and Marketing Goldacre, UK, alltrials, transparency
Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …
SHL attends the 2013 Japan PDA
June 4, 2013Manufacturing and Production auto injectors, autoinjector, autoinjectors, japan pda. shl pda
SHL once again had the honor of being invited to participate and speak at the PDA Japan 2013 (日本PDA製薬å¦ä¼š), which …
Promising signs for Novartis’ lung cancer drug
June 4, 2013Sales and Marketing ALK+, ASCO, LDK378, NSCLC, Novartis
Targeted lung cancer treatment LDK378 has been shown to help patients with the ALK+ gene mutation in a phase I trial.Novartis’ drug …
FDA issues draft guidance on contract manufacturing
June 3, 2013Manufacturing and Production FDA, GMP, Taylor
The US Food and Drug Administration FDA has published draft guidance on quality agreements between pharma companies and contract manufacturers. …
Sinovac appoints chief financial officer
June 3, 2013Manufacturing and Production, Research and Development, Sales and Marketing China, Sinovac
China-based biopharma products provider Sinovac Biotech has appointed vice president Nan Wang to be its chief financial officer. Previous CFO …
Europe votes yes on greater trial transparency
June 3, 2013Research and Development, Sales and Marketing Europe, Goldacre, alltrials, transparency
Europe has taken one step closer to increasing clinical trial transparency on the continent after MEPs voted yes on new …
Lilly and Roche back US research institute
May 31, 2013Research and Development, Sales and Marketing Roche, lilly, notre dame, research
Eli Lilly and Roche Diagnostics are among the key backers of a $360 million US life sciences research facility which …
NICE green light for Eylea
May 31, 2013Sales and Marketing Bayer, NICE, Regeneron
NICE has recommended Bayer’s injection Eylea as a treatment for neovascular (wet) age-related macular degeneration (AMD) if the manufacturer offers …
Fatality as blast rocks Teva manufacturing plant
May 31, 2013Manufacturing and Production Teva
One man died and more than 30 other people were injured after an explosion hit a manufacturing facility operated by …
AstraZeneca and CRUK partner on drug trial
May 31, 2013Sales and Marketing AstraZeneca, CRUK
AstraZeneca is partnering with Cancer Research UK to develop a new oncology medicine that targets a number of different cancers. …
Avillion appoints chief business officer
May 31, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion
Venture capitalist firm Avillion has announced the expansion of its leadership team with the appointment of Ramani Varanasi as chief …
Pfizer, UCB sell plants to smaller drugmakers
May 30, 2013Manufacturing and Production Pfizer, UCB
This week saw two pharma companies offload US manufacturing facilities to contract manufacturing organisations (CMOs), with Pfizer selling a plant …
Bad pharma, good pharma: an insider’s view
May 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy
Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …
FDA approves GSK cancer drugs
May 30, 2013Sales and Marketing FDA, GSK
The FDA has approved two of GlaxoSmithKline’s cancer pills: BRAF-inhibitor Tafinlar and the first validated MEK-inhibitor, called Mekinist, both of …
NICE U-turn on Forxiga
May 30, 2013Sales and Marketing Forxiga, NICE
NICE has recommended Bristol-Myers Squibb and AstraZeneca’s diabetes drug Forxiga in final draft guidance after turning its back on the …
SCM Pharma appoints new director
May 30, 2013Manufacturing and Production, Research and Development, Sales and Marketing SCM Pharma
UK-based contract development and manufacturing organisation SCM Pharma has strengthened its senior management team by recruiting a director. Paul Bradley …
New HIV pill for UK
May 29, 2013Sales and Marketing Gilead, HIV, stribild
Gilead Sciences has launched Stribild, a once-daily single tablet regimen to combat HIV – the virus which causes AIDS – …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
